99% Savings - Buy Just @1 Rs X
Efoceft S 250 Mg/125 Mg Injection is a prescription drug, available for use as Injection. Efoceft S 250 Mg/125 Mg Injection also has some secondary and off-label uses. These are listed below.
The optimal dosage of Efoceft S 250 Mg/125 Mg Injection is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Efoceft S 250 Mg/125 Mg Injection are Diarrhoea, Rash, Allergic reaction. Some other side effects of Efoceft S 250 Mg/125 Mg Injection have been listed ahead. These side effects of Efoceft S 250 Mg/125 Mg Injection are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Efoceft S 250 Mg/125 Mg Injection is Safe for pregnant women and Mild for women who are breastfeeding. It is important to know if Efoceft S 250 Mg/125 Mg Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Efoceft S 250 Mg/125 Mg Injection related warnings section.
Efoceft S 250 Mg/125 Mg Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Allergy are examples of such conditions.
Drug reaction of Efoceft S 250 Mg/125 Mg Injection with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Efoceft S 250 Mg/125 Mg Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Efoceft S 250 Mg/125 Mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Efoceft S 250 Mg/125 Mg Injection safe for pregnant women?
Efoceft S is safe for pregnant women.
Is the use of Efoceft S 250 Mg/125 Mg Injection safe during breastfeeding?
Side effects of Efoceft S on breastfeeding women are very mild.
What is the effect of Efoceft S 250 Mg/125 Mg Injection on the Kidneys?
In the absence of any scientific study on the side effects of Efoceft S on kidney, information on safety of Efoceft S for kidney is unavailable.
What is the effect of Efoceft S 250 Mg/125 Mg Injection on the Liver?
Efoceft S can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Efoceft S 250 Mg/125 Mg Injection on the Heart?
Information about safety of Efoceft S for heart is not available since scientific research on this is yet to be done.
If you are suffering from any of the following diseases, you should not take Efoceft S 250 Mg/125 Mg Injection unless your doctor advises you to do so -
Is this Efoceft S 250 Mg/125 Mg Injection habit forming or addictive?
No, there is no any evidence that Efoceft S 250 Mg/125 Mg Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Efoceft S 250 Mg/125 Mg Injection can make you feel drowsy.
Is it safe?
Yes, Efoceft S 250 Mg/125 Mg Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Efoceft S 250 Mg/125 Mg Injection for mental disorders.
Interaction between Food and Efoceft S 250 Mg/125 Mg Injection
You can take Efoceft S 250 Mg/125 Mg Injection with food.
Interaction between Alcohol and Efoceft S 250 Mg/125 Mg Injection
Information about the interaction of Efoceft S 250 Mg/125 Mg Injection and alcohol is not currently available because this topic has not been researched yet.
Occasionally Efoceft S can cause drug-induced thrombocytopenia (blood clot formation in a vessel). However, if you experience severe thrombocytopenia after taking this medicine, please immediately seek medical help.
Occasionally Efoceft S can cause a drug to induce hemolytic anemia (abnormal Red blood cell breakdown). However, if your blood reports are showing abnormal hemolytic anemia after taking this drug please discuss with your doctor.
Efoceft S is a brand name for ceftriaxone. It is a prescription drug that belongs to the class of medication called cephalosporins. It is a broad spectrum antibiotic, used for treating bacterial infections, such as bronchitis, gonorrhea, respiratory, ear, throat, and urinary tract infection.
Yes, you can use Efoceft S to treat pneumonia. It effectively relieves pneumonia, especially in children. Treatment can vary from patient to patient, so you must consult your doctor before consuming this medicine for pneumonia.
Yes Efoceft S is used to treat typhoid fever. It is a second-line treatment for typhoid fever. If other antibiotics are resistant to salmonella typhi then it is very effective to treat typhoid fever. However, it is best to consult your doctor about the right treatment for typhoid fever.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 160-162